Rhodotorula mucilaginosa JAASSRY1 Ameliorates Cyclophosphamide-Induced Immunosuppression by Regulating Gut Microbiota and Activation of Spleen TLR4/MyD88/NF-κB Pathway
Journal of Microbiology and Biotechnology · 21.01.2026 · 36
DOI: 10.4014/jmb.2510.10031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, online erschienen am 21.01.2026. Verfasst von Min Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Agronomy of Food Science and Technology, Yanbian University, Yanji 133002, Jilin, P.R. China. Hauptthemen laut MEDLINE: Cyclophosphamide, Spleen, NF-kappa B, Toll-Like Receptor 4. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Jilin Province Science and Technology Innovation Guidance Project, Jilin Province Agricultural Science and Technology Innovation Project, Jilin Provincial Innovation and Entrepreneurship Talent Fund.
Abstract (Originalsprache)
The present study was designed to evaluate the ameliorative effects of Rhodotorula mucilaginosa JAASSRY1 (JAASSRY1) on cyclophosphamide (CTX)-induced immunosuppression in mice.Immunocompromised mice were established by intraperitoneal injection of CTX (80 mg/kg/bw) for three consecutive days, followed by JAASSRY1 orally administered of JAASSRY1 for 21 days.Various immunological parameters, including immune organ indices, spleen cytokine levels, and immunoglobulin profiles, were evaluated.JAASSRY1 prevented CTX-induced immune damage by reversing weight loss and immune organ atrophy, suppressing the expression of IL-6, IL-17, and IFN-γ in the spleen (P < 0.01), and restoring levels of IgA and IgG, while up-regulating IL-4 (P < 0.01).Furthermore, JAASSRY1 attenuated immunosuppressive spleen injury by modulating the TLR4/MyD88/NF-κB pathway and regulating the Bax/Bcl-2 ratio.JAASSRY1 also alleviated CTX-induced dysbiosis by enhancing the abundance of Colidextribacter and reducing the levels of Parabacteroides and Bacteroides.A significant association was observed between specific gut microbiome Bacteroides and immune parameters (P < 0.01).Above all, JAASSRY1 demonstrates efficacy in ameliorating immunosuppression through the modulation of the "gut microbiotaspleen" axis, providing a basis for the development of probiotic formulations with immunomodulatory properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Agronomy of Food Science and Technology, Yanbian University, Yanji 133002, Jilin, P.R. China.
- Institute of Agro-product Process, Jilin Academy of Agricultural Science (Northeast Agricultural Research Center of China), Changchun 130033, Jilin, P.R. China.
Förderung
- Jilin Province Science and Technology Innovation Guidance Project
- Jilin Province Agricultural Science and Technology Innovation Project
- Jilin Provincial Innovation and Entrepreneurship Talent Fund
Zitieren
APA
Yang, M., He, Y., Miao, X., Sun, M., Niu, H., Hua, M., Li, D., Xu, H., & Wang, J. (2026). Rhodotorula mucilaginosa JAASSRY1 Ameliorates Cyclophosphamide-Induced Immunosuppression by Regulating Gut Microbiota and Activation of Spleen TLR4/MyD88/NF-κB Pathway. Journal of Microbiology and Biotechnology, 36. https://doi.org/10.4014/jmb.2510.10031
Vancouver
Yang M, He Y, Miao X, Sun M, Niu H, Hua M, et al. Rhodotorula mucilaginosa JAASSRY1 Ameliorates Cyclophosphamide-Induced Immunosuppression by Regulating Gut Microbiota and Activation of Spleen TLR4/MyD88/NF-κB Pathway. Journal of Microbiology and Biotechnology. 2026;36. doi:10.4014/jmb.2510.10031
BibTeX
@article{Yang2026,
author = {Yang, Min and He, Yuguang and Miao, Xinyu and Sun, Mubai and Niu, Honghong and Hua, Mei and Li, Da and Xu, Hongyan and Wang, Jinghui},
title = {Rhodotorula mucilaginosa JAASSRY1 Ameliorates Cyclophosphamide-Induced Immunosuppression by Regulating Gut Microbiota and Activation of Spleen TLR4/MyD88/NF-κB Pathway},
journal = {Journal of Microbiology and Biotechnology},
year = {2026},
volume = {36},
doi = {10.4014/jmb.2510.10031}
}
EUVIMED